Research programme: hormone therapies - JangoBio
Latest Information Update: 04 Feb 2022
At a glance
- Originator JangoBio
- Class Hormonal replacements; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Andropause; Menopausal syndrome
Most Recent Events
- 01 Feb 2022 Early research in Andropause is ongoing in USA
- 01 Feb 2022 Early research in Menopausal syndrome is ongoing in USA
- 28 Nov 2021 No recent reports of development identified for research development in Andropause in USA